Top Ten Equity Holdings and Exposures

RNS Number : 1536W

Polar Cap Gbl Healthcare Growth&IT

06 February 2017

 

6^th February 2017

Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31^st January 2017 and full Portfolio listing as at 30^th December 2016 available from company's website

Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31^st January 2017 the top ten equity holdings and the sector and geographic breakdown were as follows:   

Top 10 Holdings	%
Merck & Co	7.6%
Pfizer	7.4%
Johnson & Johnson	6.0%
GlaxoSmithKline	5.0%
Sanofi	4.9%
Roche	4.7%
Novartis	4.6%
Astellas Pharma	3.8%
Merck KGaA	3.7%
Bristol Myers Squibb	3.1%
Total	50.8%

Sector Exposure	%
Pharmaceuticals	62.4%
Healthcare Equipment	9.4%
Biotechnology	8.4%
Healthcare REITs	5.7%
Healthcare Services	4.3%
Healthcare Facilities	3.8%
Managed Healthcare	3.2%
Healthcare Supplies	0.8%
Life & Health Insurance	0.6%
Life Sciences Tools & Services	0.5%
Healthcare Distributors	0.2%
Cash	0.8%
Total	100.0%

Geographic Exposure	%
United States	50.3%
United Kingdom	10.7%
Switzerland	10.0%
Japan	5.9%
France	4.9%
Germany	4.2%
Australia	2.9%
Ireland	2.8%
Israel	2.8%
Canada	2.1%
Italy	0.8%
India	0.8%
Denmark	0.6%
Norway	0.5%
Cash	0.8%
Total	100%

The monthly factsheet will usually be available on the Company's website on the 10^th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

 

END

 

 

PFUKMGGZKVKGNZM